SCHEMBL29816631

SCHEMBL29816631

O=c1c2ccccc2[nH]c2ccncc12

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.72
KDM4E B2RXH2 3/20 0.67
ALDH1A1 P00352 3/20 0.67
GAA P10253 3/20 0.67
HPGD P15428 2/20 0.67
SMN1; SMN2 Q16637 2/20 0.67
GLA P06280 2/20 0.67
HTT P42858 2/20 0.67
LMNA P02545 1/20 0.67
ATM Q13315 1/20 0.67
PARP1 P09874 3/20 0.64
GABRP O00591 1/20 0.61
GABRD O14764 1/20 0.61
IKBKB O14920 1/20 0.61
AURKA O14965 1/20 0.61
CHUK O15111 1/20 0.61
PIM1 P11309 1/20 0.61
TOP1 P11387 1/20 0.61
GABRA1 P14867 1/20 0.61
IDO1 P14902 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15131720 0.92 ACHE (0.62) ACHEKDM4EALDH1A1GAAHPGD
SCHEMBL12396546 0.90 ACHE (0.61) ACHEKDM4EALDH1A1GAAHPGD
SCHEMBL15131722 0.86 ACHE (0.58) ACHEKDM4EALDH1A1GAAHPGD
SCHEMBL9043755 0.86 PARP1 (0.81) ACHEKDM4EALDH1A1GAAHPGD
SCHEMBL9042961 0.84 PARP1 (0.76) ACHEKDM4EALDH1A1GAAHPGD
SCHEMBL9040656 0.84 PARP1 (0.81) ACHEKDM4EALDH1A1GAAHPGD
SCHEMBL121401 0.84 ACHE (1.00) ACHEKDM4EALDH1A1GAAHPGD
SCHEMBL29382084 0.84 ACHE (1.00) ACHEKDM4EALDH1A1GAAHPGD
Hydrochloric Acid SCHEMBL4436954 0.82 ACHE (0.96) ACHEKDM4EALDH1A1GAAHPGD
Hydrochloric Acid SCHEMBL3234011 0.82 ACHE (0.96) ACHEKDM4EALDH1A1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11434239-B2 Aza-dihydro-acridone derivatives ARTAX BIOPHARMA INC. (US) 2022-09-06 US claimed
US-11434239-B2 Aza-dihydro-acridone derivatives ARTAX BIOPHARMA INC. (US) 2022-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11434239-B2 Aza-dihydro-acridone derivatives CDKN1A, CD4, MKI67 ACHE 4772/4885KDM4E 1211/4885ALDH1A1 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.